<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Komodo Health — Prospect Detail</title>
  <link rel="stylesheet" href="styles.css">
</head>
<body>

<header class="site-header">
  <h1>Prospect Detail</h1>
</header>

<div class="container">
  <a href="index.html" class="back-link">&larr; Back to All Prospects</a>

  <div class="detail-header">
    <span class="badge health" style="font-size:.8rem;">Digital Health</span>
    <h1>36. Komodo Health</h1>
    <p class="meta">Healthcare Intelligence Platform</p>
  </div>

  <div class="section">
    <h3>1. Startup Name</h3>
    <p><strong>Komodo Health</strong></p>
  </div>

  <div class="section">
    <h3>2. Founder Contact</h3>
    <p><strong>Arif Nathoo, MD MPA</strong> — Co-Founder & CEO</p>
    <p>Harvard Medical School MD, Harvard Kennedy School MPA</p>
  </div>

  <div class="section">
    <h3>3. Product Overview</h3>
    <p>Komodo Health is a healthcare intelligence company that maps patient journeys across the entire healthcare system. Using the Healthcare Map™ — the industry's largest patient-level dataset — they enable life sciences companies, payers, and providers to make data-driven decisions about drug development, commercialization, and care delivery.</p>
  </div>

  <div class="section">
    <h3>4. Funding Stage</h3>
    <p><strong>Late Stage</strong> — Raised over $600M from investors including ICONIQ Growth, Tiger Global, and HealthQuest Capital. Valued at approximately $3.3B.</p>
  </div>

  <div class="section">
    <h3>5. How I Found the Company</h3>
    <p>Discovered as a prominent Harvard HMS/HKS alumni success story, frequently featured in healthcare intelligence and life sciences technology coverage.</p>
  </div>

  <div class="strengths-weaknesses">
    <div class="section">
      <h3>Strengths</h3>
      <ul>
        <li><strong>Unmatched data asset:</strong> Healthcare Map covers 330M+ patient journeys, creating significant barriers to entry.</li>
        <li><strong>Diversified revenue:</strong> Serves pharma, payers, and providers with different use cases and buying cycles.</li>
      </ul>
    </div>
    <div class="section">
      <h3>Weaknesses</h3>
      <ul>
        <li><strong>Late-stage valuation:</strong> $3.3B valuation may limit upside for new investors in current market.</li>
        <li><strong>Regulatory risk:</strong> Healthcare data privacy regulations could impact data collection and usage.</li>
      </ul>
    </div>
  </div>

  <div class="section">
    <h3>7. Five Questions for the Team</h3>
    <ol class="questions-list">
      <li>How do you maintain data freshness and accuracy across your Healthcare Map?</li>
      <li>What is your revenue breakdown between pharma, payer, and provider segments?</li>
      <li>How do you navigate HIPAA and state privacy regulations for patient-level data?</li>
      <li>What is your competitive moat versus IQVIA, Veeva, and other healthcare data companies?</li>
      <li>What are your IPO plans given the current market conditions?</li>
    </ol>
  </div>

  <a href="index.html" class="back-link">&larr; Back to All Prospects</a>
</div>

</body>
</html>
